215 related articles for article (PubMed ID: 12709796)
1. Comparison of three treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome.
Baroutis G; Kaleyias J; Liarou T; Papathoma E; Hatzistamatiou Z; Costalos C
Eur J Pediatr; 2003 Jul; 162(7-8):476-480. PubMed ID: 12709796
[TBL] [Abstract][Full Text] [Related]
2. Poractant alfa and beractant treatment of very premature infants with respiratory distress syndrome.
Fujii AM; Patel SM; Allen R; Doros G; Guo CY; Testa S
J Perinatol; 2010 Oct; 30(10):665-70. PubMed ID: 20336076
[TBL] [Abstract][Full Text] [Related]
3. Patent ductus arteriosus hemodynamics in very premature infants treated with poractant alfa or beractant for respiratory distress syndrome.
Fujii A; Allen R; Doros G; O'Brien S
J Perinatol; 2010 Oct; 30(10):671-6. PubMed ID: 20336077
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of surfactant-TA, calfactant and poractant alfa for preterm infants with respiratory distress syndrome: a retrospective study.
Jeon GW; Oh M; Sin JB
Yonsei Med J; 2015 Mar; 56(2):433-9. PubMed ID: 25683992
[TBL] [Abstract][Full Text] [Related]
5. A randomized trial comparing beractant and poractant treatment in neonatal respiratory distress syndrome.
Malloy CA; Nicoski P; Muraskas JK
Acta Paediatr; 2005 Jun; 94(6):779-84. PubMed ID: 16188788
[TBL] [Abstract][Full Text] [Related]
6. Randomized clinical trial comparing two natural surfactant preparations to treat respiratory distress syndrome.
Hammoud M; Al-Kazmi N; Alshemmiri M; Thalib L; Ranjani VT; Devarajan LV; Elsori H
J Matern Fetal Neonatal Med; 2004 Mar; 15(3):167-75. PubMed ID: 15280142
[TBL] [Abstract][Full Text] [Related]
7. Perfusion index variability in preterm infants treated with two different natural surfactants for respiratory distress syndrome.
Karadag N; Dilli D; Zenciroglu A; Aydin B; Beken S; Okumus N
Am J Perinatol; 2014 Nov; 31(11):1015-22. PubMed ID: 24566756
[TBL] [Abstract][Full Text] [Related]
8. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
[TBL] [Abstract][Full Text] [Related]
9. A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants.
Ramanathan R; Rasmussen MR; Gerstmann DR; Finer N; Sekar K;
Am J Perinatol; 2004 Apr; 21(3):109-19. PubMed ID: 15085492
[TBL] [Abstract][Full Text] [Related]
10. Choosing a right surfactant for respiratory distress syndrome treatment.
Ramanathan R
Neonatology; 2009; 95(1):1-5. PubMed ID: 18832858
[TBL] [Abstract][Full Text] [Related]
11. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants.
Moya FR; Gadzinowski J; Bancalari E; Salinas V; Kopelman B; Bancalari A; Kornacka MK; Merritt TA; Segal R; Schaber CJ; Tsai H; Massaro J; d'Agostino R;
Pediatrics; 2005 Apr; 115(4):1018-29. PubMed ID: 15805380
[TBL] [Abstract][Full Text] [Related]
12. Poractant alfa versus beractant for respiratory distress syndrome in preterm infants: a retrospective cohort study.
Paul S; Rao S; Kohan R; McMichael J; French N; Zhang G; Simmer K
J Paediatr Child Health; 2013 Oct; 49(10):839-44. PubMed ID: 23802801
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Infasurf (calf lung surfactant extract) to Survanta (Beractant) in the treatment and prevention of respiratory distress syndrome.
Bloom BT; Kattwinkel J; Hall RT; Delmore PM; Egan EA; Trout JR; Malloy MH; Brown DR; Holzman IR; Coghill CH; Carlo WA; Pramanik AK; McCaffree MA; Toubas PL; Laudert S; Gratny LL; Weatherstone KB; Seguin JH; Willett LD; Gutcher GR; Mueller DH; Topper WH
Pediatrics; 1997 Jul; 100(1):31-8. PubMed ID: 9200357
[TBL] [Abstract][Full Text] [Related]
14. Effect of two different early rescue surfactant treatments on mortality in preterm infants with respiratory distress syndrome.
Kadıoğlu Şimşek G; Kanmaz Kutman HG; Canpolat FE; Oğuz ŞS
Clin Respir J; 2020 Mar; 14(3):285-290. PubMed ID: 31814293
[TBL] [Abstract][Full Text] [Related]
15. Synthetic Surfactant CHF5633 Compared with Poractant Alfa in the Treatment of Neonatal Respiratory Distress Syndrome: A Multicenter, Double-Blind, Randomized, Controlled Clinical Trial.
Ramanathan R; Biniwale M; Sekar K; Hanna N; Golombek S; Bhatia J; Naylor M; Fabbri L; Varoli G; Santoro D; Del Buono D; Piccinno A; Dammann CE
J Pediatr; 2020 Oct; 225():90-96.e1. PubMed ID: 32553868
[TBL] [Abstract][Full Text] [Related]
16. Effects of Two Different Exogenous Surfactant Preparations on Serial Peripheral Perfusion Index and Tissue Carbon Monoxide Measurements in Preterm Infants with Severe Respiratory Distress Syndrome.
Terek D; Gonulal D; Koroglu OA; Yalaz M; Akisu M; Kultursay N
Pediatr Neonatol; 2015 Aug; 56(4):248-55. PubMed ID: 25603725
[TBL] [Abstract][Full Text] [Related]
17. The short-term outcome of a large cohort of very preterm infants treated with poractant alfa (Curosurf) for respiratory distress syndrome. A postmarketing phase IV study.
Lamboley-Gilmert G; Lacaze-Masmonteil T;
Paediatr Drugs; 2003; 5(9):639-45. PubMed ID: 12956620
[TBL] [Abstract][Full Text] [Related]
18. Observational study to compare the clinical efficacy of the natural surfactants Alveofact and Curosurf in the treatment of respiratory distress syndrome in premature infants.
Proquitté H; Dushe T; Hammer H; Rüdiger M; Schmalisch G; Wauer RR
Respir Med; 2007 Jan; 101(1):169-76. PubMed ID: 16698258
[TBL] [Abstract][Full Text] [Related]
19. Randomised clinical trial of two treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome.
Speer CP; Gefeller O; Groneck P; Laufkötter E; Roll C; Hanssler L; Harms K; Herting E; Boenisch H; Windeler J
Arch Dis Child Fetal Neonatal Ed; 1995 Jan; 72(1):F8-13. PubMed ID: 7743295
[TBL] [Abstract][Full Text] [Related]
20. Early treatment of respiratory distress syndrome with bovine surfactant in very preterm infants: a multicenter controlled clinical trial.
Gortner L; Bartmann P; Pohlandt F; Bernsau U; Porz F; Hellwege HH; Seitz RC; Hieronimi G; Bremer C; Jorch G
Pediatr Pulmonol; 1992 Sep; 14(1):4-9. PubMed ID: 1437342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
